Bipartisan leaders of House panel press drug companies on opioid crisis

Bipartisan leaders of House panel press drug companies on opioid crisis
© Getty

Bipartisan leaders of the House Energy and Commerce Committee are pressing three drug companies for answers about their role in the opioid crisis.

The panel’s leaders sent letters to three companies that make opioids, Insys Therapeutics, Mallinckrodt Pharmaceuticals and Purdue Pharma, requesting a briefing with the committee and answers to questions about how the companies marketed opioids and whether they looked the other way when they saw evidence of abuse of their products.

Purdue Pharma, the maker of OxyContin, has long been under scrutiny for misleadingly marketing its product as nonaddictive. The company pleaded guilty in 2007 to misrepresenting the drug’s addictive qualities.

ADVERTISEMENT

The committee’s letter to Purdue questions whether the company actually changed its marketing behavior after 2007.

The letter also points to evidence in media reports that the company knew the drug was being abused earlier than 2000, when officials have said they learned about the problem.

“If Purdue personnel were in fact aware of reports of OxyContin being abused prior to 2000, then that may call into question testimony company executives provided to Congress, including before this Committee,” the lawmakers write.

Earlier this year, Purdue said it would stop marketing opioids to doctors and laid off its sales force.

The letter was signed by the panel’s Chairman, Greg WaldenGregory (Greg) Paul WaldenConservative groups defend tech from GOP crackdown Overnight Health Care — Presented by PCMA — Sanders unveils new Medicare for all bill with backing from other 2020 Dems | White House slams Sanders' rollout | Drugmakers, 'middlemen' point fingers on insulin pricing House votes to reinstate Obama-era net neutrality rules MORE (R-Ore.), as well as ranking member Frank Pallone Jr.Frank Joseph PalloneAnti-smoking advocates question industry motives for backing higher purchasing age Overnight Health Care: DOJ charges doctors over illegal opioid prescriptions | Cummings accuses GOP of obstructing drug pricing probe | Sanders courts Republican voters with 'Medicare for All' | Dems probe funding of anti-abortion group House Democrats probe Trump administration's funding of anti-abortion group MORE (D-N.J.) and Reps. Gregg HarperGregory (Gregg) Livingston HarperCongress sends bill overhauling sexual harassment policy to Trump's desk Dems cry foul in undecided N.C. race Mississippi New Members 2019 MORE (R-Miss.), Diana DeGetteDiana Louise DeGetteAnti-smoking advocates question industry motives for backing higher purchasing age House Democrats probe Trump administration's funding of anti-abortion group Dems push back on White House suggesting they're 'not smart enough' for Trump's tax returns MORE (D-Colo.), Morgan GriffithHoward (Morgan) Morgan GriffithOvernight Energy: Senate Dems introduce Green New Deal alternative | Six Republicans named to House climate panel | Wheeler confirmed to lead EPA Six Republicans named to House climate panel House passes bill expressing support for NATO MORE (R-Va.) and Kathy CastorKatherine (Kathy) Anne CastorEnvironmentalists see victory with Green New Deal blitz Dem lawmaker offers tool for 'filling in the blanks' of Green New Deal Overnight Energy: EPA watchdog issues rare 'alert' on toxic substances data | Trump to announce new orders to speed up pipeline permits | New Keystone XL pipeline permit challenged in court | Congress approves seven-state drought bill MORE (D-Fla.).

The committee has been investigating the opioid crisis for months, including looking into “pill dumping,” where drug distributors flooded small towns, particularly in West Virginia, with millions of opioid pills.